Focal demyelination in Alzheimer's disease and transgenic mouse models
Focal demyelination in Alzheimer's disease and transgenic mouse models
复制标题
DOI:
10.1007/s00401-010-0657-2
复制
发表时间:
2010-05-01
影响因子:
12.7
通讯作者:
Dickson, Tracey C.
中科院分区:
文献类型:
--
作者:
Mitew, Stanislaw;Kirkcaldie, Matthew T. K.;Dickson, Tracey C.
We have investigated alterations in myelin associated with A beta plaques, a major pathological hallmark of Alzheimer's disease (AD), in human tissue and relevant transgenic mice models. Using quantitative morphological techniques, we determined that fibrillar A beta pathology in the grey matter of the neocortex was associated with focal demyelination in human presenilin-1 familial, sporadic and preclinical AD cases, as well as in two mouse transgenic models of AD, compared with age-matched control tissue. This demyelination was most pronounced at the core of A beta plaques. Furthermore, we found a focal loss of oligodendrocytes in sporadic and preclinical AD cases associated with A beta plaque cores. In human and transgenic mice alike, plaque-free neocortical regions showed no significant demyelination or oligodendrocyte loss compared with controls. Dystrophic neurites associated with the plaques were also demyelinated. We suggest that such plaque-associated focal demyelination of the cortical grey matter might impair cortical processing, and may also be associated with aberrant axonal sprouting that underlies dystrophic neurite formation.